Pregnancy outcomes after exposure to interferon beta

An international collaboration of researchers led from StatFinn & EPID Research in Mölndal, Sweden and Espoo, Finland have published a comparative cohort study using linked national healthcare register data from Sweden and Finland. The study investigated the risk of adverse pregnancy outcomes following maternal perinatal exposure to interferon beta in the treatment of multiple sclerosis. More information can be found here.

Photo by Solen Feyissa on Unsplash